BIODIEM
BioDiem is an Australian biopharmaceutical company that is focused on developing and commercialising vaccines and infectious disease therapies. Their business model is to generate income from partnerships including with other vaccine and infectious disease treatment companies through existing and new licences to its LAIV vaccine and other technologies. They have an established influenza vaccine licensing business. Their revenue comes from licence fees and royalties on sales.
BIODIEM
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Address:
Victoria, British Columbia, Canada
Country:
Canada
Website Url:
http://www.biodiem.com
Status:
Active
Contact:
+ 61 3 9692 7240
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API WordPress Content Delivery Network Microsoft Exchange Online Office 365 Mail Google Maps JsDelivr
Similar Organizations
AltiBio
AltiBio is a biopharmaceutical firm that develops orphan therapeutics.
Paradigm Pharmaceuticals
Paradigm Biopharma Ltd is an Australian biopharmaceutical company.
Semifore
Semifore is an ongoing healthy company
Takeda Oncology
Takeda Oncology is a leading biopharmaceutical company.
Current Employees Featured
Official Site Inspections
http://www.biodiem.com
- Host name: s142.syd2.hostingplatform.net.au
- IP address: 103.27.34.128
- Location: Gold Coast Australia
- Latitude: -27.9997
- Longitude: 153.4344
- Timezone: Australia/Brisbane
- Postal: 4217

More informations about "BioDiem"
Company Overview - BioDiem
Dec 3, 2024 The technology is licensed to BioDiem by the Institute of Experimental Medicine (IEM) in St Petersburg, Russia. Egg-based production: The version of the LAIV vaccine that โฆSee details»
BioDiem - Crunchbase Company Profile & Funding
BioDiem is an Australian biopharmaceutical company that is focused on developing and commercialising vaccines and infectious disease therapies. โฆSee details»
Board and management - BioDiem
Dec 3, 2024 Ms Julie Phillips is Chief Executive Officer and a Director of BioDiem Ltd and Managing Director of BioDiemโs subsidiary, Opal Biosciences Ltd. She has a strong โฆSee details»
BioDiem - Products, Competitors, Financials, Employees, โฆ
BioDiem is an Australian biopharmaceutical company focused on developing and commercialising vaccines and infectious disease therapies. The company generates income through โฆSee details»
BioDiem Ltd Company Profile - Overview - GlobalData
BioDiem partners with other vaccine and infectious disease treatment companies by licensing its LAIV vaccine and other technologies. The LAIV is licensed to World Health Organization as โฆSee details»
BioDiem Company Profile - Office Locations, Competitors ... - Craft
See insights on BioDiem including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
BioDiem Ltd. Profile
BioDiem is an Australian biopharmaceutical company that is focused on developing and commercialising vaccines and infectious disease therapies. Our business model is to generate โฆSee details»
BIODIEM LTD Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for BIODIEM LTD of SOUTH MELBOURNE, VICTORIA. Get the latest business insights from Dun & Bradstreet.See details»
Partner Network - BioDiem
BioDiemโs Global Partnering Network Institute of Experimental Medicine (IEM), St. Petersburg, Russia World Health Organization Program for Appropriate Technology in Health (PATH) โฆSee details»
BioDiem - VentureRadar
BioDiem is an Australian biopharmaceutical company that is focused on developing and commercialising vaccines and infectious disease therapies. Our lead asset, the LAIV (Live โฆSee details»
BioDiem - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 28, 2025 BioDiem is a funded company based in South Melbourne (Australia), founded in 2001. It operates as a Developing and commercializing vaccine technology and infectious โฆSee details»
Org Chart Biodiem - The Official Board
The org chart of Biodiem contains its 4 main executives including Julie Phillips and Stefan Ross.See details»
BioDiem 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, acquisitions, investors, and executives for BioDiem. Use the PitchBook Platform to explore the full profile.See details»
BioDiem CEO and Key Executive Team - Craft.co
BioDiem's Non-Executive Director is Larisa Rudenko. Other executives include Damien Hannes, Chairman; Julie Phillips, Chief Executive Officer and Executive Director and 1 others. See the โฆSee details»
LAIV - BioDiem
BioDiemโs licensing partners in India and China The WHO has issued sublicences to the LAIV technology to the Serum Institute of India Ltd and the Government Pharmaceutical โฆSee details»
BioDiem Ltd Analysis & Company Information - GlobalData
BioDiem Ltd (BioDiem) discovers, develops, and commercializes vaccines and infectious disease therapies. It focuses on developing vaccines and novel therapeutic candidates for the โฆSee details»
Technology and Products - BioDiem
Dec 3, 2024 Technology and Products BioDiem is an Australian-based biotechnology company with a focus on developing and commercialising vaccine and infectious disease therapies. The โฆSee details»
BioDiem Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore BioDiem Ltd. with its drug pipeline, therapeutic area, technology platform, 3 news, Disease Domain:Infectious Diseases, Technology Platform:Small molecule drug, Live โฆSee details»
Announcements - BioDiem
Apr 22, 2024 BioDiem » AnnouncementsAnnouncementsSee details»